(ZEISS: Oberkochen, Germany) -- ZEISS Ventures is investing in life-science startup InSphero to further advance the adoption of 3D microtissues in research and drug development. InSphero AG, a pioneer in 3D spheroid and cell-based assays in pharmaceutical drug discovery and safety testing, has raised an eight-figure amount in its latest funding round. It will utilize the proceeds to commercialize its cryopreservation technology to enable further growth and scalability. ZEISS Ventures is participating in the financing round, along with internal and external investors.

 …